Immune dysregulation and chronic inflammation are central contributors to many diseases. Curcuma longa L. and Echinacea purpurea (L.) Moench are widely used medicinal plants with extensive preclinical evidence supporting immunomodulatory effects. Their key metabolites, curcuminoids, turmerones, alkamides, polysaccharides, and caffeic acid derivatives, engage with critical pathways, including NF-κB, MAPK, JAK/STAT, and Nrf2. This interaction modulates cytokine production, oxidative stress responses, and both innate and adaptive immune activities. Although numerous mechanistic and early clinical studies support these actions, human evidence remains inconsistent, partly due to poor and variable oral bioavailability and substantial heterogeneity in extract composition, despite the existence of some standardized preparations. Recent technological strategies, including micelles, phytosomes, phospholipid complexes, nanoemulsions, polymeric nanoparticles, and liposomal systems, have improved solubility, stability, and systemic exposure of key metabolites, particularly curcuminoids. However, clinical results are still limited and often derived from small or heterogeneous trials. This review summarizes the ethnopharmacological background, mechanistic data, clinical findings, and formulation advances for both species and highlights the translational barriers that restrict their therapeutic application. Rigorous clinical studies using standardized and technologically optimized preparations are required to determine the true immunomodulatory potential of C. longa and E. purpurea.

Biofouling in membrane filtration systems poses significant operational challenges, leading to decreased permeate flux. The aim of this work was to study the anti-biofilm properties of new nanofiltration membranes produced via layer-by-layer, LBL, assembly by coating a polyvinylidene fluoride (PVDF) support with a polyethylenimine (PEI) and poly(acrylic acid)/graphene oxide (PAA-GO) mixture. The membranes were characterized according to contact angle, scanning electron microscopy (SEM), atomic force microscopy and their Z-potential. Biofilm quantification and characterization were carried out using crystal violet staining and SEM, while bacterial viability was assessed by using colony-forming units. The membrane with three bilayers ((PAA-PEI)3/PVDF) showed a roughness of 77.78 nm. The incorporation of GO ((GO/PAA-PEI)3/PVDF) produced a membrane with a smoother surface (roughness of 26.92 nm) and showed salt rejections of 16% and 68% for NaCl and Na2SO4, respectively. A significant reduction, ranging from 82.37 to 77.30%, in biofilm formation produced by S. aureus and E. coli were observed on modified membranes. Additionally, the bacterial viability on the modified membranes was markedly reduced (67.42–99.98%). Our results show that the modified membranes exhibited both antibiofilm and antimicrobial capacities, suggesting that these properties mainly depend on the properties of the modifying agents, as the initial adherence on the membrane surface was not totally suppressed, but the proliferation and formation of EPSs were prevented.

Tea, derived from the leaves of Camellia sinensis is globally recognized for its cultural significance and potential health benefits. While extensively studied in adults, the effects of tea consumption in children remain underexplored. This review examines tea′s bioactive compounds, such as catechins, flavonoids, and L-theanine, and their cognitive, cardiovascular, metabolic, oral, and hepatoprotective benefits with a critical overview of its consumption in pediatric populations. Additionally, the review addresses potential risks, including caffeine-related effects, interference with iron absorption, and hepatotoxicity at high doses. Emerging evidence suggests that tea is a beneficial alternative to sugar-sweetened beverages for children when consumed in moderation. However, caution is warranted regarding caffeine content and the balance of bioactive components. This analysis underscores the importance of further research to establish safe and effective guidelines for tea consumption in children.

White-matter development during fetal life represents one of the most vulnerable processes to environmental disruption, as it relies on the precisely timed proliferation, migration, and differentiation of oligodendrocyte lineage cells. Among environmental threats, exposure to toxic compounds contained in tobacco smoke and vaping aerosols represents a major yet preventable risk during pregnancy. Despite growing awareness, tobacco smoking remains widespread, and a substantial proportion of the population—including pregnant women—continues to perceive electronic nicotine delivery systems (ENDS) as less harmful, a misconception that contributes to persistent prenatal exposure. These products expose the fetus to numerous substances that readily cross the placenta and reach the developing brain, including compounds with endocrine-disrupting activity, where they interfere with white-matter development. Epidemiological and neuroimaging studies consistently reveal microstructural alterations in white matter that correlate with long-term cognitive and behavioral impairments in offspring exposed in utero. These alterations may arise from both nicotine-specific pathways and the actions of other toxicants in cigarette smoke and ENDS aerosols that cross the placenta and disrupt white-matter emergence and maturation. Preclinical research provides mechanistic insight: nicotine acts directly on nicotinic acetylcholine receptors (nAChRs) in oligodendrocyte precursor cells, disrupting calcium signaling and differentiation, while additional constituents of smoke and vaping aerosols also affect astrocyte and microglial function and disturb the extracellular milieu required for proper myelination.